Regeneron Pharmaceuticals
REGN
NASDAQ
IPO1991
about REGN
Regeneron Pharmaceuticals is a leading biopharmaceutical company focused on researching, developing, and producing innovative medicines and genetic-based treatments, including its widely used treatment for eye diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $741.59 | $746.05 | $734.38 | $78.5B | 810.24K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$14.09 | 16.39 | 21.17 | 27.35% | 38.89% | 0.47% |